Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma

被引:359
|
作者
Alsayed, Yazan
Ngo, Hai
Runnels, Judith
Leleu, Xavier
Singha, Ujjal K.
Pitsillides, Costas M.
Spencer, Joel A.
Kimlinger, Teresa
Ghobrial, Joanna M. [1 ]
Jia, Xiaoying
Lu, Ganwei
Timm, Michael
Kumar, Ashok
Cote, Daniel
Veilleux, Israel
Hedin, Karen E.
Roodman, G. David
WitZig, Thomas E.
Kung, Andrew L.
Hideshima, Teru
Anderson, Kenneth C.
Lin, Charles P.
Ghobrial, Irene M.
机构
[1] Univ Pittsburgh, Inst Canc, Dept Internal Med, Div Hematol Oncol, Pittsburgh, PA 15260 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed,Adv Microscopy Progam, Boston, MA USA
[5] Mayo Clin, Coll Med, Rochester, MN USA
[6] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA
[7] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1182/blood-2006-07-035857
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanisms by which multiple myeloma (MM) cells migrate and home to the bone marrow are not well understood. In this study, we sought to determine the effect of the chemokine SDF-1 (CXCL12) and its receptor CXCR4 on the migration and homing of MM cells. We demonstrated that CXCR4 is differentially expressed at high levels in the peripheral blood and is down-regulated in the bone marrow in response to high levels of SDF-1. SDF-1 induced motility, internalization, and cytoskeletal rearrangement in MM cells evidenced by confocal microscopy. The specific CXCR4 inhibitor AMD3100 and the anti-CXCR4 antibody MAB171 inhibited the migration of MM cells in vitro. CXCR4 knockdown experiments demonstrated that SDF-1-dependent migration was regulated by the PI3K and ERK/MAPK pathways but not by p38 MAPK. In addition, we demonstrated that AMD3100 inhibited the homing of MM cells to the bone marrow niches using in vivo flow cytometry, in vivo confocal microscopy, and whole body bioluminescence imaging. This study, therefore, demonstrates that SDF-1/CXCR4 is a critical regulator of MM homing and that it provides the framework for inhibitors of this pathway to be used in future clinical trials to abrogate MM trafficking.
引用
收藏
页码:2708 / 2717
页数:10
相关论文
共 50 条
  • [31] Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses
    Salcedo, R
    Oppenheim, JJ
    MICROCIRCULATION, 2003, 10 (3-4) : 359 - 370
  • [32] SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis
    Dillenburg-Pilla, Patricia
    Patel, Vyomesh
    Mikelis, Constantinos M.
    Zarate-Blades, Carlos Rodrigo
    Doci, Colleen L.
    Amornphimoltham, Panomwat
    Wang, Zhiyong
    Martin, Daniel
    Leelahavanichkul, Kantima
    Dorsam, Robert T.
    Masedunskas, Andrius
    Weigert, Roberto
    Molinolo, Alfredo A.
    Gutkind, J. Silvio
    FASEB JOURNAL, 2015, 29 (03): : 1056 - 1068
  • [33] Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1α (SDF-1α/CXCL12)
    Veldkamp, Christopher T.
    Seibert, Christoph
    Peterson, Francis C.
    Sakmar, Thomas P.
    Volkman, Brian F.
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 359 (05) : 1400 - 1409
  • [34] The CXCL12(SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy
    ZHOU Yu
    CAO Han-Bo
    LI Wen-Jun
    ZHAO Li
    ChineseJournalofNaturalMedicines, 2018, 16 (11) : 801 - 810
  • [35] Multiple myeloma and microenvironment formation: the role of CXCR4/CXCL12 chemokine pathway
    Beider, K.
    Shimoni, A.
    Gutwein, O.
    Leiba, M.
    Ribakovsky, E.
    Bloom, N.
    Peled, A.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S319 - S319
  • [36] CXCL12/CXCR4 signalling in neuronal cell migration
    Tiveron, Marie-Catherine
    Cremer, Harold
    CURRENT OPINION IN NEUROBIOLOGY, 2008, 18 (03) : 237 - 244
  • [37] The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy
    Zhou Yu
    Cao Han-Bo
    Li Wen-Jun
    Zhao Li
    CHINESE JOURNAL OF NATURAL MEDICINES, 2018, 16 (11) : 801 - 810
  • [38] Multiple Myeloma and Microenvironment Formation: The Role of CXCR4/CXCL12 Chemokine Pathway
    Beider, Katia
    Shimoni, Avichai
    Gutwein, Odit
    Leiba, Merav
    Ribakovsky, Elena
    Bloom, Nina
    Peled, Amnon
    Nagler, Arnon
    BLOOD, 2010, 116 (21) : 1221 - 1221
  • [39] Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4: Implications for hematopoietic stem & progenitor cell homing and engraftment.
    Christopherson, KW
    Porecha, NK
    Hangoc, G
    Broxmeyer, HE
    BLOOD, 2004, 104 (11) : 339A - 339A
  • [40] The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease
    Karin, Nathan
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (03) : 463 - 473